课题基金 / 基金详情

项目摘要

项目成果

Aravind Asokan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Respiratory tract pathogens such as the human parainfluenza virus and SARS coronavirus effectively infect human airways by exploiting a diverse set of cell surface glycans and glycoprotein receptors encountered in airway cell types. In case of adeno-associated viruses (AAV), serotypes 1, 5, 6 and more recently, AAV9 have been shown to efficiently transduce airways in vitro and in vivo, albeit with striking species-specific and serotype-specific differences. The goal of this proposal is to elucidate molecular and cellular determinants of airway tropism in AAV serotypes. To achieve such, we have devised a comprehensive approach that hinges on molecular manipulation of AAV capsids through mutagenesis, biochemical reagents for identification of glycans and co-receptors that mediate AAV airway cell entry and relevant in vitro models of the human respiratory tract. The strategies described herein will (a) define AAV capsid structural elements at the amino acid level that determine airway tropism, and (b) enable identification of cell surface components including glycans and integrin subunits that dictate AAV tropism for different airway cell types. The proposed studies will help provide a comprehensive picture of the mechanisms underlying AAV airway cell entry as well as provide insight into species-specific differences in AAV airway tropism. If successful, this knowledge may facilitate improvements in AAV vectors as well as in the design of preclinical/clinical studies focused on gene therapy of airway diseases such as cystic fibrosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting AAV silencing in humanized mice
  • 批准号:
    10562376
  • 项目类别:
  • 资助金额:
    $61.62万
  • 财政年份:
    2023
  • 负责人:
    Aravind Asokan
  • 依托单位:
Engineering the biology of AAV secretion and production
  • 批准号:
    10656028
  • 项目类别:
  • 资助金额:
    $45.7万
  • 财政年份:
    2023
  • 负责人:
    Aravind Asokan
  • 依托单位:
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
  • 批准号:
    10667569
  • 项目类别:
  • 资助金额:
    $47.71万
  • 财政年份:
    2022
  • 负责人:
    Aravind Asokan
  • 依托单位:
海外基金